bioAffinity Technologies, Inc. — Director's Dealing 2023

Jul 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: bioAffinity Technologies, Inc. (BIAF)
CIK: 0001712762
Period of Report: 2023-06-06

Reporting Person: Dougherty Michael Philip (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-06	Common Stock	A	52356	$1.91	Acquired	52356	Direct

Footnotes

F1: Represents a grant from bioAffinity Technologies, Inc. (the "Company") to Mr. Dougherty of 52,356 shares of common stock, par value $0.007, pursuant to the terms of an employment offer letter dated April 11, 2023, which was approved by the Board of Directors of the Company on May 11, 2023.